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Hexavalent  chromium,  Cr(VI),  is an environmental  toxicant  and  is  associated  with  hep-
atotoxicity.  However,  very  little is  known  about  the intracellular  antioxidant  defense
mechanism  against  Cr(VI)-induced  cytotoxicity  in  hepatocytes.  In the  present  study,  we
cultured  human  liver  (HepG2)  cells  in  the  absence  or  presence  of  Cr(VI)  and  determined  its
effect  on cellular  oxidative  stress,  mitochondrial  damage,  apoptosis  and  the  expression  of
the  transcription  factor  Nrf2  and  the  Nrf2-dependent  antioxidant  enzymes.  Cr(VI)  intoxi-
cation at  a dose of 0, 3.125,  6.25,  12.5,  25,  or 50 M for 24  h  exhibited  a dose  dependent
cytotoxic  effects  in hepatocytes.  Besides,  Cr(VI)  induced  oxidative  stress  and  subsequent
mitochondrial  damage.  Cr(VI)  also  induced  caspase  3-dependent  apoptosis  in  HepG2  cells.
In addition,  Cr(VI)  induced  the  translocation  of Nrf2  into  the  nucleus  and  up-regulated  theApoptosis
Antioxidant signaling
Nrf2
expression  of Nrf2-dependent  antioxidant  enzymes,  including  SOD2,  GCLC,  and  HO1.  Our
present  experimental  data  support  the  notion  that Cr(VI)  caused  mitochondrial  damage,
apoptosis,  oxidative  stress,  and  subsequently  lead  to  a  strong  induction  of  HO1,  GCLC  and
SOD2 via  the  Nrf-2  signaling  pathway  in  hepatocytes.
© 2015  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is  an  open  access  article  under
the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Chromium (Cr), is a naturally occurring element that
exist in a variety of oxidation states (−2 to +6). Among the
several ionic forms of Cr, hexavalent chromium [Cr(VI)] is
the most toxic that can readily cross cellular membranes via
nonspeciﬁc anion transporters. After entering into the cell,
Abbreviations: Cr(VI), hexavalent chromium; GCLC, glutamyl cysteine
ligase catalytic subunit; HO1, heme oxygenase-1; MDA, malonaldehyde;
Nrf2, nuclear erythroid 2-related factor 2; ROS, reactive oxygen species;
SOD, superoxide dismutase; TUNEL, terminal deoxynucleotidyl trans-
ferase (TdT) nick end labeling.
∗ Corresponding author at: Division of Molecular Medicine, Bose Insti-
tute, P-1/12, CIT Scheme VII M,  Kolkata 700054, West Bengal, India.
Tel.: +91 33 2569 3243; fax: +91 33 2355 3886.
E-mail addresses: parames@jcbose.ac.in, parames 95@yahoo.co.in
(P.C. Sil).
http://dx.doi.org/10.1016/j.toxrep.2015.03.013
2214-7500/© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open
org/licenses/by-nc-nd/4.0/).Cr(VI) is reduced by cellular reductants to produce reactive
intermediates, including Cr(V), Cr(IV), Cr(III) and reactive
oxygen species (ROS). These species can cause DNA strand
breaks, base modiﬁcation and lipid peroxidation, thereby
disrupting cellular integrity and inducing toxic as well as
mutagenic effects [1]. Cr(VI) is being used in more than
50 different industries worldwide. It has been reported
that Cr(VI) has many uses in pigment production, textile,
leather tannery, wood processing, chrome plating, met-
allurgical and chemical industries, stainless steel factory,
welding, cement manufacturing factory, ceramic, glass,
photographic industries, catalytic converter for automo-
bile, heat resistance and as an anti-rusting agent in cooling
plant, etc. [2,3]. Owing to the increased use by the indus-
tries and improper disposal of these Cr(VI) waste in the
environment, Cr(VI) levels continue to increase in the soil,
water and air that creates severe environmental pollution
[4–7]. Besides, occupational exposure (via inhalation and
 access article under the CC BY-NC-ND license (http://creativecommons.
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kin contact) to Cr(VI) has also been found among approx-
mately half a million workers in the United States and
everal millions throughout the world [5].
Due to environmental or occupational exposure to
r(VI), people are suffering from increased risk of asthma,
asal septum, skin ulcerations and respiratory cancers [5].
r(VI) is also known to cause allergic dermatitis, cytotoxic,
enotoxic, immunotoxic and carcinogenic effects both in
umans and laboratory animals [2,8,9]. Besides, Cr(VI)
xposure also induces hepatotoxicity associated with
xidative stress, tissue injury, mitochondrial damage and
poptosis [10–14]. Although chromium and chromium-
ontaining compounds has gained much interest in the
eld of toxicology research, appropriate in vitro model
s warranted to fully understand the mechanism of cyto-
oxicity and oxidative stress. Moreover, the intracellular
ntioxidant defense mechanism against Cr(VI)-induced
ytotoxicity is not clearly understood and not yet been
tudied in details. The intracellular antioxidant defense
echanism is composed by high cellular level of glu-
athione (GSH), and a family of phase II detoxiﬁcation
nzymes, including glutamyl cysteine ligase catalytic sub-
nit (GCLC), heme oxygenase-1 (HO1) and Mn-superoxide
ismutase (SOD2) which are controlled by a transcrip-
ion factor nuclear erythroid 2-related factor 2 (Nrf2).
nder oxidative stress condition, Nrf2 is translocated to
he nucleus from cytosol, where it binds to the antioxi-
ant response element (ARE), resulting in a cytoprotective
esponse by inducing the transcription of antioxidant genes
15–20].
Therefore, the objectives of the present in vitro study
ere to: (i) determine the cytotoxic effect of Cr(VI) on
uman liver (HepG2) cells; (ii) evaluate the effect of Cr(VI)
n oxidative stress and mitochondrial damage; and (iii)
xplore the effect of Cr(VI) on Nrf2-dependent antioxidant
ignaling pathways.
. Materials and methods
.1. Chemicals
Anti caspase 3, anti HO1, anti Nrf2, anti SOD2, anti
ctin, anti lamin B1 and anti GCLC antibodies were pur-
hased from Abcam (Cambridge, MA,  USA). K2Cr2O7 and
ll other reagents were bought from Sisco Research Labo-
atory (Mumbai, India).
.2. Cell culture and treatment
Human liver (HepG2) cells were obtained from National
enter for Cell Science (NCCS), Pune, India. The cells
ere cultured in DMEM supplemented with 10% FBS and
00 U/mL penicillin–streptomycin in a humidiﬁed incuba-
or maintained at 37 ◦C and 5% CO2. For in vitro cytotoxicity
xperiments, cells were treated with different concentra-
ions of K2Cr2O7 (0, 3.125, 6.25, 12.5, 25 and 50 M)  for 24 h
n DMEM media supplemented with 1% FBS and 100 U/mL
enicillin–streptomycin. The reason for the selection of
hese doses is as follows.
The maximum permissible limit of Cr(VI) in drinking
ater is 0.05 mg/L (0.17 M)  as recommended by WHO.ts 2 (2015) 600–608 601
Since our aim was to evaluate the cytotoxic effect of Cr(VI)
on HepG2 cells, we  planned to investigate that effect at
a dose of 3.125–50 M by performing a dose-dependent
study following the report of Patlolla et al. [10].
For the NAC pre-treatment experiments, cells were pre-
treated with NAC (5 mM)  for 1 h followed by K2Cr2O7
treatment at different doses (0, 3.125, 6.25, 12.5, 25 and
50 M)  for 24 h.
2.3. Cell viability assay
Cells were seeded (5 × 105 cells/well) onto 96-well ﬂat
bottom culture plates and incubated for 24 h at 37 ◦C
in a 5% CO2 incubator. The old medium was  replaced
by fresh DMEM media containing 1% FBS. Cells were
then treated with different concentrations of K2Cr2O7 (0,
3.125, 6.25, 12.5, 25 and 50 M)  for 24 h in a humidi-
ﬁed incubator at 37 ◦C and 5% CO2. Cell viability assay
was performed using the MTT  {3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyl-tetrazolium bromide} method. The
absorbance was read at a wavelength of 570 nm using
microtiter plate reader [21].
2.4. Intracellular ROS measurement
Cells were incubated with 10 M 2′,7′-
dichlorodihydroﬂuorescein diacetate (H2-DCFDA) in a
humidiﬁed incubator at 37 ◦C for 30 min. Cells were
then washed with phosphate-buffered saline (PBS) and
resuspended in PBS. Fluorescence emission was measured
by ﬂow cytometry using a 525 nm band pass ﬁlter. In
addition, for microscopic measurement cells were ﬁrst
grown on glass slide, treated with K2Cr2O7 followed by
incubation with 10 M H2-DCFDA at 37 ◦C for 30 min. Then
cells were washed with PBS, mounted with ﬂuorescent
medium, covered with glass cover slip and observed under
a ﬂuorescent microscope [22].
2.5. Cell cycle analysis
After treatment, cells were washed with PBS,
trypsinized and ﬁxed with 95% ethanol for 24 h at
−20 ◦C. Cells were then washed and incubated with
0.05 mg/mL  PI and 1 g/mL RNase A at 37 ◦C for 30 min,
and analyzed by ﬂow cytometry. The cells belonging to the
sub-G1 population were considered to be apoptotic cells.
The percentage of cells in each phase of the cell cycle was
determined.
2.6. Assessment of lipid peroxidation
After treatment, cells were washed with PBS and resus-
pended in a buffer containing Hepes (10 mM),  KCl (3 mM),
NaCl (130 mM),  NaH2PO4 (1 mM)  and glucose (10 mM), and
pH 7.4. After that cells were lysed by sonication. Intra-
cellular lipid peroxidation was  measured in the form of
malondialdehyde (MDA) content following the methods of
Esterbauer and Cheeseman [23]. In brief, samples contain-
ing 1 mg  of protein was mixed with 1 mL  trichloro acetic
acid (20%) and 2 mL  thiobarbituric acid (0.67%). The content
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Fig. 1. Cytotoxicity of Cr(VI) in HepG2 cells. (A) Cell viability relative to the control (100%) in HepG2 cells was measured using the MTT. Cells were pre-treated
r(VI) in
ps. (B) Cwith 5 mM NAC for 1 h and then exposed to different concentrations of C
compared to the control. #P < 0.05 compared with the Cr(VI)-treated grou
in  M for 24 h. M1  represents the percentage of sub-G1g populations.
was heated for 1 h at 100 ◦C. After cooling, the precipitate
was removed by centrifugation. Thee absorbance of the
sample was measured at 535 nm,  against a suitable blank.
2.7. JC1 staining
Cells were ﬁrst grown on glass slide, treated with
K2Cr2O7 followed by incubation with 10 M JC1 at 37 ◦C
for 15 min. Then cells were washed with PBS, mounted
with ﬂuorescent medium, covered with glass cover slip and
observed under a ﬂuorescent microscope.
2.8. TUNEL assay
Cells were ﬁrst grown on glass slides and after get-
ting 80% cell conﬂuency the cells were treated with
K2Cr2O7. Then the cells were washed with PBS, ﬁxed with
4% paraformaldehyde, washed again and incubated with
0.1% Triton X-100. TdT-mediated dUTP nick-end labeling
(TUNEL) detection of apoptotic cells was performed in the
treated cells according to the manufacturer’s instructions
(Invitrogen, USA).
2.9. Immunocytochemistry
Cells were ﬁrst grown on glass slides and after getting
80% cell conﬂuency the cells were treated with K2Cr2O7.
Then the cells were washed with PBS, ﬁxed with 4%
paraformaldehyde, washed again and incubated with 0.1%
Triton X-100. Cells were then incubated with the appro-
priate primary antibodies in 1% bovine serum albumin at M for 24 h. All values were expressed as mean ± S.E.M. (n = 3).*P < 0.05
ell cycle analysis after treatment with different concentrations of Cr(VI)
room temperature. After that cells were again washed and
incubated with an appropriate ﬂuorescence-conjugated
secondary antibody at room temperature. Finally, the cells
were mounted with ﬂuorescent medium, covered with
glass cover slip and observed under a ﬂuorescent micro-
scope [22].
2.10. Immunoblotting
HepG2 cells were lysed in RIPA lysis buffer contain-
ing protease inhibitors. Equal amounts of protein were
resolved by 10% sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) and proteins were then
electrophoretically transferred to a PVDF. Membranes were
blocked at room temperature with 5% non-fat dry milk
for 2 h to prevent non speciﬁc binding and then incubated
with primary antibodies overnight at 4 ◦C. Immunoreac-
tivity was  detected through sequential incubation with
horseradish peroxidase-conjugated secondary antibodies
and enhanced chemiluminescence reagents.
2.11. Quantiﬁcation of images
Relative intensity of all ﬂuorescent images and densito-
metry of western blot were carried out by Imagej software.
2.12. Statistical analysisAll the values are expressed as mean ± SEM (n = 3).
Signiﬁcant differences between the groups were deter-
mined with SPSS 10.0 software (SPSS Inc., Chicago, IL,
J. Das et al. / Toxicology Reports 2 (2015) 600–608 603
Fig. 2. Oxidative stress induced by Cr(VI) in HepG2 cells. (A) Lipid peroxidation relative to the control (100%) in HepG2 cells exposed to different concen-
trations of Cr(VI) in M for 24 h. All values are expressed as mean ± S.E.M. (n = 3). *P < 0.05 compared to the control. (B) ROS production in HepG2 cells after
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OS  production in cells was  measured ﬂow cytometrically by using a cati
SA) for Windows using one-way analysis of variance
ANOVA) and the group means were compared by
tudent–Newman–Keuls post hoc tests. A difference was
onsidered signiﬁcant at the P < 0.05 level.
. Results
.1. Cr(VI) induced cytotoxicity in HepG2 cells
To determine the cytotoxic effect of Cr(VI), cell viability
as measured after culturing the cells in the presence of
r(VI) in different concentrations (0, 3.125, 6.25, 12.5, 25,
nd 50 M)  for 24 h. As shown in Fig. 1A, Cr(VI) decreased
he cell viability in HepG2 cells. To further quantify the
ead cells, a ﬂow cytometric analysis was performed byepG2 cells after treatment with 12.5 M Cr(VI) for 1 and 2 h respectively.
orescent dye, 2′ ,7′-dichlorodihydroﬂuorescein diacetate (H2-DCFDA).
staining with PI after treatment with Cr(VI) at different
doses for 24 h. The population of dead cells was  represented
as a hypodiploid sub-G1 DNA peak, which was increased
by stimulation with Cr(VI) in a dose-dependent manner
(Fig. 1B). However, pre-treatment with NAC (5 mM,  1 h) sig-
niﬁcantly reduced Cr(VI)-induced cell viability loss (Fig. 1A)
in HepG2 cells.
3.2. Cr(VI) induced oxidative stress and disrupted
mitochondrial membrane potential in HepG2 cellsTo investigate the involvement of oxidative stress in
Cr(VI)-induced cell death, we  measured the cellular MDA
level (indicative of lipid peroxidation) and formation of
reactive oxygen species (ROS) in HepG2 cells exposed to
604 J. Das et al. / Toxicology Reports 2 (2015) 600–608
Fig. 3. Effects of Cr(VI) on ROS and MMP  in HepG2 cells. (A) Representative ﬂuorescent images of HepG2 cells, after staining with cationic ﬂuorescent
dye,  2′ ,7′-dichlorodihydroﬂuorescein diacetate (H2-DCFDA). (B) Representative ﬂuorescent images of HepG2 cells, after staining with ﬂuorescent dye, JC1.
Cells  were ﬁrst grown on glass slide, treated with 12.5 M and 25 M Cr(VI) for 24 h followed by incubation with 10 M H2-DCFDA or 10 M JC1 at 37 ◦C
for  15 min  at 37 ◦C for 30 min. Then cells were washed with PBS, mounted with ﬂuorescent medium, covered with glass cover slip and observed under
a  ﬂuorescent microscope. For JC1 staining, the merged images captured under green and red ﬁlter were provided. Graphs represent the average green
dicates
HO1 expression in HepG2 cells when exposed to 12.5 andﬂuorescence intensity ± SEM of separate experiments in each group. “a” in
where  Pa < 0.05.
Cr(VI). After 24 h of Cr(VI) intoxication, we observed that
both the MDA  and ROS levels increased dose depend-
ently (Fig. 2A and B). However, we also observed that
production of intracellular ROS started between 1 and 2 h
when the cells were exposed to 12.5 M Cr(VI) (Fig. 2C).
Cr(VI) induced ROS formation was also conﬁrmed by the
ﬂuorescence microscopic analysis. As shown in Fig. 3A,
the cells exposed to Cr(VI) with increasing doses showed
enhanced green ﬂuorescence. The alteration of mitochon-
drial membrane potential, as evident by JC1 dye straining,
was depicted in Fig. 3B. Compared with the untreated
control, a signiﬁcant increase in the green ﬂuorescence
intensity was observed in the cells exposed to increasing
dose of Cr(VI), indicating that mitochondria experience a
loss of membrane polarization, which corresponds to a
loss in function. These results indicated that Cr(VI)-induced
cytotoxicity was mediated through oxidative stress and
subsequent mitochondrial damage.
3.3. Cr(VI) induced apoptotic cell death in HepG2 cells
Next, the mode of cell death due to Cr(VI) intoxica-
tion has been investigated. Cr(VI) induced apoptosis in
HepG2 cells as was evidenced from both TUNEL staining
and immunocytochemical localization of cleaved caspase 3.
Treatment with 25 and 50 M Cr(VI) for 24 h increased the the signiﬁcant difference between the control and Cr(VI) exposed groups
proportion of TUNEL-positive cells signiﬁcantly compared
to that observed in the control cells (Fig. 4A). In addition,
immunoﬂuorescence study showed that Cr(VI) increased
the cleaved caspase 3 expression in HepG2 cells when the
cells were exposed to 12.5 and 25 M Cr(VI) for 24 h com-
pared with untreated control (Fig. 4B).
3.4. Cr(VI) activated the antioxidant signaling pathways
in HepG2 cells
To investigate whether Nrf2-dependent antioxidant
defense mechanism is activated during Cr(VI)-induced
oxidative stress mediated cytotoxicity in HepG2 cells,
we examined the Nrf2 nuclear translocation and the
expressions of HO1, GCLC and SOD2. Immunoﬂuorescence
experiments showed a weak, diffuse staining of Nrf2 in
untreated control. However, Cr(VI) intoxication resulted in
a marked increase in nuclear Nrf2 staining (Fig. 5A). The
nuclear accumulation of Nrf2 by Cr(VI) was also supported
by western blot analysis (Fig. 5C). In addition, immuno-
ﬂuorescence study also showed that Cr(VI) increased the25 M Cr(VI) for 24 h compared with untreated control
(Fig. 5B). Furthermore, Cr(VI) also augmented the expres-
sion of GCLC and SOD2 proteins compared to the untreated
cells (Fig. 5B).
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Fig. 4. Cr(VI) induced apoptosis in HepG2 cells. (A) Representative ﬂuorescent images of TUNEL-positive (green) cells after exposure to 25 M and 50 M
Cr(VI) for 24 h. Cell nuclei were counterstained with PI (red). (B) Immunocytochemical localization of active caspase 3 by ﬂuorescent microscope after
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. Discussion
This study was undertaken to determine the in vitro
ytotoxic effects of Cr(VI) on human liver (HepG2) cells.
e have further checked the effects of Cr(VI) on oxidative
tress, mitochondrial damage, apoptosis and antioxidant
ignaling mechanisms in HepG2 cells. To achieve these,
ells were ﬁrst treated with Cr(VI) at a dose of 0, 3.125,
.25, 12.5, 25, or 50 M for 24 h, and then biochemical, ﬂow
ytometric, ﬂuorescence microscopic and immunoblotting
nalyses were performed.
Our results showed that Cr(VI) exhibited a dose depend-
nt cytotoxic effects in HepG2 cells, as evident from
educed cell viability and increased hypodiploid sub-G1
NA populations. Next we investigated whether oxidative
tress and mitochondrial dysfunction played any role inen ﬂuorescence intensity ± SEM of separate experiments in each group.
oups where Pa < 0.05.
our current experimental model. We  observed that Cr(VI)
intoxication dose dependently increased lipid peroxida-
tion and the production of intracellular reactive oxygen
species (ROS) when the cells were exposed to Cr(VI) for
24 hr. We  have also found that ROS production has been
one of the earliest phenomena for the Cr(VI)-induced cyto-
toxicity, as the ROS production has started to increase
between 1 and 2 h when the cells were exposed to 12.5 M
Cr(VI). Besides, mitochondrial membrane potential (MMP)
was also decreased dose dependently after Cr(VI) intoxi-
cation for 24 h. We  observed a signiﬁcant increase in the
green ﬂuorescence intensity in the cells exposed to Cr(VI),
indicating mitochondria membrane depolarization. Stud-
ies with ROS inhibitor, NAC showed that it could reduce
Cr(VI)-induced cell death. Therefore, oxidative stress and
subsequent mitochondrial damage play a crucial role in
606 J. Das et al. / Toxicology Reports 2 (2015) 600–608
Fig. 5. Effects of Cr(VI) on the antioxidant signaling pathways in HepG2 cells. (A) Immunocytochemical localization of Nrf2 by ﬂuorescent microscope after
exposure to 12.5 M and 25 M Cr(VI) for 24 h. (B) Immunocytochemical localization of HO1 by ﬂuorescent microscope after exposure to 12.5 M and
25  M Cr(VI) for 24 h. (C) Western blot analysis of Nrf2, Gclc and SOD2 proteins in HepG2 cells after treatment with different concentrations of Cr(VI) for
24  h. GCLC, SOD2 and HO1 proteins were analyzed in the whole cell protein lysate. Nrf2 was analyzed in the nuclear protein fraction. Graphs represent
l localiz
en the cthe  average green ﬂuorescence intensity ± SEM for immunocytochemica
experiments in each group. “a” indicates the signiﬁcant difference betwe
Cr(VI) induced cytotoxicity. These results are also sup-
ported by previous reports where the authors have shown
that Cr(VI)-induced cytotoxicity in hepatocytes has been
mediated through oxidative stress and mitochondrial dys-
function [10–12].ation of Nrf2 and HO1 and average ± SEM for Western blot of separate
ontrol and Cr(VI) exposed groups where Pa < 0.05.
After that we have investigated whether Cr(VI)-induced
cytotoxic effect was mediated through apoptotic cell death
pathway in HepG2 cells. We  observed that intoxication
with Cr(VI) for 24 hr signiﬁcantly increased the proportion
of TUNEL-positive cells and cleaved caspase 3 expression
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in  LPS-stimulated macrophages, Free Radic. Biol. Med. 49 (2011)ig. 6. Schematic diagram of Cr(VI) induced cytotoxicity in HepG2 cells.
n HepG2 cells compared to that observed in the control
ells. These results are in agreement with previous reports
here the authors have demonstrated that Cr(VI) induced
OS-dependent and caspase 3-mediated apoptosis in hepa-
ocytes [13,14].
The fate of cells undergoing death or survival under
xidative stress condition depends on the balance between
he formation of ROS and the enzymatic as well as
on-enzymatic antioxidant molecules. Therefore, we  have
nvestigated the role of the redox-sensitive transcription
actor, Nrf2 and its associated antioxidant defense mech-
nism as a target of Cr(VI) toxicity. In our present study,
e observed that Cr(VI) induced the translocation of Nrf2
nto the nucleus, as evident by the results of the immu-
oﬂuorescence study and western blot analysis. We  have
lso observed that Cr(VI) induced the upregulation of sev-
ral antioxidant enzyme expression that are regulated by
he Nrf2-ARE dependent pathways. These enzymes include
OD2 (scavenges mitochondrial superoxide; [24]), GCLC (is
he rate limiting enzyme for GSH biosynthesis; [25]) and
O1 (a novel cytoprotective antioxidant enzyme; [26,27]).
herefore, the importance of Nrf2 signaling in terms of a
ontribution to antioxidant response, such as HO1, SOD2
nd GCLC up regulation, may  merit further investigation
o develop an improved Cr(VI) antagonists in the future to
ombat Cr(VI)-induced hepatotoxicity.
In conclusion, we say that Cr(VI) induces mitochon-
rial damage, apoptosis as well as cellular oxidative stress,
nd subsequently leads to a strong induction of HO1, GCLC
nd SOD2 via the Nrf-2 signaling pathway in hepatocytes
Fig. 6).
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